Daily Technical Analysis Weekly Analysis Monthly Analysis Renko chart MACD chart Bollinger Bands chart Stochastics charts Force Index charts

(GLAXO) Glaxosmithkline Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Glaxosmithkline Pharmaceuticals | (GLAXO) share price targets

Complete technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) by charts plus indicators, forecast predictions and share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Glaxosmithkline Pharmaceuticals trades in NSE in Pharmaceuticals sector.

Showing technical analysis as on 2026-01-14 View latest technical analysis

10 day averaged volume of Glaxosmithkline Pharmaceuticals is 65641

Date	Daily Closing Price	Open	High	Low	Volume
14 Wed Jan 2026	2394.80	2369.00	2411.50	2361.00	0.855 times
13 Tue Jan 2026	2369.10	2397.00	2417.10	2349.00	0.893 times
12 Mon Jan 2026	2397.10	2372.00	2403.80	2337.60	0.678 times
09 Fri Jan 2026	2372.10	2390.00	2404.00	2350.00	1.24 times
08 Thu Jan 2026	2398.70	2455.00	2455.30	2386.80	0.669 times
07 Wed Jan 2026	2459.80	2483.30	2528.00	2448.00	2.373 times
06 Tue Jan 2026	2483.30	2456.00	2504.00	2437.20	0.695 times
05 Mon Jan 2026	2456.20	2484.90	2484.90	2452.00	0.673 times
02 Fri Jan 2026	2483.80	2461.30	2487.70	2443.90	0.418 times
01 Thu Jan 2026	2455.90	2476.00	2476.00	2442.50	0.621 times

My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 2403.1, but if it comes above 2403.1, then a intra day buy could be more profitable.
If you take a sell trade below 2403.1, then use 2403.1 as stoploss and 2331.9 as target. However if you take a buy trade in stock , then use 2403.1 as stoploss and 2462.33 as target.

Share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Target	2337.60
Upside Target	2528.00
Upside Target	2550.10
Upside Target	2601.00
Upside Target	2608.90
Upside Target	2622.60
Upside Target	2635.00
Upside Target	2694.00
Upside Target	2795.90
Upside Target	2883.40

Intraday share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Intraday Target	2349.23
Downside Intraday Target	2303.67
Upside Intraday Target	2428.73
Upside Intraday Target	2462.67
Downside Intraday Target	2383.17

Weekly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Weekly Closing Price	Open	High	Low	Volume
14 Wed Jan 2026	2394.80	2372.00	2417.10	2337.60	0.429 times
09 Fri Jan 2026	2372.10	2484.90	2528.00	2350.00	0.494 times
02 Fri Jan 2026	2483.80	2483.00	2487.70	2362.60	4.21 times
26 Fri Dec 2025	2464.30	2530.10	2550.10	2459.50	0.545 times
19 Fri Dec 2025	2529.00	2587.70	2608.90	2506.70	0.48 times

Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.

Monthly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Monthly Closing Price	Open	High	Low	Volume
14 Wed Jan 2026	2394.80	2476.00	2528.00	2337.60	0.249 times
31 Wed Dec 2025	2473.60	2551.00	2635.00	2362.60	1.29 times
28 Fri Nov 2025	2569.50	2644.00	2694.00	2404.20	1.54 times
31 Fri Oct 2025	2618.60	2659.70	2795.90	2601.00	0.628 times

Scroll below to view daily charts

Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.

Indicators analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Glaxosmithkline Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a SELL signal for Glaxosmithkline Pharmaceuticals in short term and the sell signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Glaxosmithkline Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

CCI has generated a buy signal for Glaxosmithkline Pharmaceuticals in short term but BUY signal is weak.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Glaxosmithkline Pharmaceuticals is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2426.11 and Glaxosmithkline Pharmaceuticals (GLAXO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Glaxosmithkline Pharmaceuticals (GLAXO) stock. Volume based technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) stock is negative.

Glaxosmithkline Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.